Express Pharma
          Home  ?  Latest Updates  ?  Dr Reddy’s launches generic sapropterin dihydrochloride tablets for oral use in US

          Dr Reddy’s launches generic sapropterin dihydrochloride tablets for oral use in US

          They are indicated to reduce blood phenylalanine levels in adult and paediatric patients with hyperphenylalaninemia due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria

          0 2,551
          Read Article

          Dr Reddy’s Laboratories announced the launch of a generic version of sapropterin dihydrochloride tablets, for oral use.

          Sapropterin dihydrochloride is a phenylalanine hydroxylase activator indicated to reduce blood phenylalanine (Phe) levels in adult and paediatric patients one month of age and older with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU). It is to be used in conjunction with a Phe-restricted diet.

          “This product demonstrates that we are actively expanding the breadth of our portfolio with a treatment for a rare disease. We are pleased to provide financial support to patients by offering a co-pay card program for eligible patients, details will be available on our website,” says Marc Kikuchi, CEO, North America Generics, Dr Reddy’s Laboratories.

          Dr Reddy’s Sapropterin Dihydrochloride Tablets, 100 mg are available in bottle count sizes of 120.

          Leave A Reply

          Your email address will not be published.

           Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
          Know More?
          close-image
          免费观看欧美一级牲交片